Keyphrases
COVID-19
100%
Indonesia
96%
Surabaya
58%
AIDS/HIV
46%
AIDS Patients
31%
Human Immunodeficiency Virus Type 1 (HIV-1)
30%
Drug Resistance mutations
23%
Clinical Impact
21%
Opportunistic Infections
21%
Platform Trials
21%
University Hospital
21%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
21%
Human Immunodeficiency Virus Drug Resistance
21%
Hydroxychloroquine
21%
Usual Care
14%
CRF01_AE
14%
Clinical Manifestations
13%
Oral Candidiasis
13%
HIV Drug Resistance
13%
Meta-analysis
13%
COVID-19 Infection
13%
COVID-19 Pandemic
13%
Disease Severity
12%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
12%
Micronutrient Intake
10%
Randomized Double-blind
10%
Drug-treated
10%
Critically Ill COVID-19 Patients
10%
Acute Invasive Fungal Rhinosinusitis
10%
Empagliflozin
10%
Isolation Period
10%
University Teaching Hospital
10%
Surveillance Strategy
10%
Bronchial Asthma
10%
Clinical Progression
10%
HIV-1 Genotyping
10%
Boron-modified
10%
COVID-19 Antibody
10%
Internist
10%
Oral Pre-exposure Prophylaxis
10%
West Papua
10%
Moderate COVID-19
10%
Lopinavir
10%
Multicenter Clinical Trial
10%
Randomized Evaluation
10%
Systematic Meta-analysis
10%
Vulnerability
10%
Post-pandemic
10%
Drug Combination
10%
Ventilatory Support
10%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
76%
Drug Resistance
41%
Diseases
40%
Infection
40%
Prevalence
35%
Coronavirinae
28%
SARS Coronavirus
25%
Acquired Immune Deficiency Syndrome
23%
Opportunistic Infection
21%
Hydroxychloroquine
21%
Placebo
14%
Thrush
13%
Pandemic
12%
Disease Severity
12%
Empagliflozin
10%
RNA
10%
Quantum Dot
10%
Carbon Quantum Dot
10%
Lung Infiltrate
10%
Lopinavir Plus Ritonavir
10%
Doxycycline
10%
Combination Drug
10%
Fungal Sinusitis
10%
Azithromycin
10%
Dengue
10%
Clinical Study
10%
Mixed Infection
10%
Bacterial Infection
10%
Asthma
10%
Chloroquine
10%
Integrase
10%
Dengue Virus
9%
Human Immunodeficiency Virus 1
7%
HIV Drug Resistance
7%
Human Immunodeficiency Virus Infection
6%
Proteinase
5%
RNA Directed DNA Polymerase
5%
Medicine and Dentistry
COVID-19
83%
Infection
27%
HIV/AIDS
21%
Drug Resistance
21%
Human Immunodeficiency Virus
20%
Human Immunodeficiency Virus 1
17%
Prevalence
14%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Disease Severity
12%
Patient Referral
12%
Diseases
11%
Systematic Review
10%
Empagliflozin
10%
COVID-19 Therapy
10%
Drug Megadose
10%
RNA
10%
SARS Coronavirus
10%
Antibiotic Therapy
10%
Screening Test
10%
Pulmonary Infiltrate
10%
Fungal Sinusitis
10%
Dengue Fever
10%
Oral Candidiasis
10%
Mixed Infection
10%
Acquired Immune Deficiency Syndrome
10%
Placebo
10%
Hydroxychloroquine
10%
Chloroquine
10%
Artificial Respiration
9%
Antiretroviral Therapy
9%
Virus
9%
Dengue Virus
9%
Resistance Mutation
7%
Bacterial Infection
7%
Virus Shedding
6%
HIV Drug Resistance
6%
Odds Ratio
5%
